-
公开(公告)号:US20100158973A1
公开(公告)日:2010-06-24
申请号:US12282735
申请日:2007-03-13
申请人: Lola Weiss , Vardiella Meiner , Eran Leitersdorf , Shimon Slavin , Raphael Mechoulam , Ruth Gallily , Chaim Lotan , Ronen Durst , Thea Pugatsch
发明人: Lola Weiss , Vardiella Meiner , Eran Leitersdorf , Shimon Slavin , Raphael Mechoulam , Ruth Gallily , Chaim Lotan , Ronen Durst , Thea Pugatsch
CPC分类号: A61K31/352 , A61K31/35
摘要: The present invention provides the use of a Cannabidiol (CBD) compound for the preparation of a pharmaceutical composition for treatment as well as for the prevention of at least one fundamental parameter affecting a vascular system selected from (a) the cardiovascular system; (b) the peripheral vascular system; or (c) a combination of (a) and (b); as well as pharmaceutical compositions and therapeutic methods for treating the above. A fundamental parameter may include blood/plasma lipid profile; atherosclerosis plaque load; size of heart scar; thickness of heart scar; and cardiac function in general. In accordance with a preferred embodiment the invention concerns treatment of heart scars as well as preventing the formation of heart scars.
摘要翻译: 本发明提供大麻二醇(CBD)化合物用于制备用于治疗的药物组合物以及用于预防影响选自(a)心血管系统的血管系统的至少一个基本参数的用途; (b)外周血管系统; 或(c)(a)和(b)的组合; 以及用于治疗上述的药物组合物和治疗方法。 基本参数可以包括血液/血浆脂质分布; 动脉粥样硬化斑块负荷; 心脏瘢痕大小; 心脏瘢痕厚度; 和心脏功能一般。 根据优选实施方案,本发明涉及心脏瘢痕的治疗以及防止形成心脏瘢痕。